secwatch.observer — SEC 8-K summary
======================================

Issuer:     SELECT MEDICAL HOLDINGS CORP (SEM)
CIK:        0001320414
Form:       8-K
Filed at:   2026-04-30T23:59:59+00:00
Accession:  0001104659-26-053056
Event type: earnings
Sentiment:  negative
Materiality: 0.65
Item codes: 2.02, 5.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Select Medical Q1 EPS $0.35 vs $0.44; revenue +5% to $1.42B; merger on track
----------------------------------------------------------------------------

- Revenue $1,421.5M +5.0% YoY; net income $63.8M vs $74.7M; diluted EPS $0.35 vs $0.44.
- Adj EBITDA $141.6M down from $151.4M; critical illness hospital margin fell to 11.5% from 13.6%.
- Rehab hospital revenue +14.5% to $351.9M, Adj EBITDA +15.1% to $81.1M, margin stable at 23.0%.
- Merger with WCAS XIV on track; HSR waiting period expired Apr 27; expected close mid-2026 at $16.50/share.
- FY 2026 outlook reaffirmed: rev $5.6-5.8B, Adj EBITDA $520-540M, diluted EPS $1.22-1.32.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1320414/000110465926053056/0001104659-26-053056-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1320414/000110465926053056/tm2613082d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-26-053056

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer